Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial
Background: Little is known about the safety and effectiveness of early interventional treatment (EIT) with intranasal corticosteroids for seasonal allergic rhinitis. We designed a double-blinded, randomized, placebo-controlled 12-week trial of EIT with mometasone furoate nasal spray (MFNS) for Japa...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015302239 |
id |
doaj-542293918de04a32b67b62e8ceab05d3 |
---|---|
record_format |
Article |
spelling |
doaj-542293918de04a32b67b62e8ceab05d32020-11-24T22:24:43ZengElsevierAllergology International1323-89302012-01-0161229530410.2332/allergolint.11-OA-0382Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled TrialSeiichiro Makihara0Mitsuhiro Okano1Tazuko Fujiwara2Masayo Kimura3Takaya Higaki4Takenori Haruna5Yohei Noda6Kengo Kanai7Shin Kariya8Kazunori Nishizaki9Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Otolaryngology-Head & Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Background: Little is known about the safety and effectiveness of early interventional treatment (EIT) with intranasal corticosteroids for seasonal allergic rhinitis. We designed a double-blinded, randomized, placebo-controlled 12-week trial of EIT with mometasone furoate nasal spray (MFNS) for Japanese cedar/cypress pollinosis (JCCP). Methods: A total of 50 JCCP patients received MFNS (200 ^g once daily: n = 25) or placebo (n = 25) starting on February 1, 2010. Treatments continued until the end of April. The primary endpoint was the comparison of the total nasal symptom score (TNSS) between the MFNS and placebo groups. The secondary endpoints included comparisons of QOL, daytime sleepiness, nasal ECP levels, and safety. Results: Continuous dispersion of Japanese cedar pollen began on February 22. Although the placebo group showed a significant worsening of symptoms after the start of the continuous dispersion, no worsening occurred in the MFNS group. A significant difference in the TNSS between the two groups was seen starting at 4 weeks after the treatment. Similar results were seen for QOL and sleepiness. Nasal ECP levels in March were significantly lower in the MFNS group. A total of 56% of the MFNS group progressed to a persistent allergic rhinitis state in accordance with the ARIA classification, as opposed to 84% of the placebo group. MFNS was well tolerated, and the plasma cortisol concentrations were similar between the two groups. Conclusions: EIT with MFNS for JCCP is both safe and effective. This treatment can potentially lessen symptoms and help pollinosis patients remain in the intermittent state.http://www.sciencedirect.com/science/article/pii/S1323893015302239early interventional treatmentECPintranasal corticosteroidsJapanese cedar/cypress pollinosistotal nasal symptom score |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Seiichiro Makihara Mitsuhiro Okano Tazuko Fujiwara Masayo Kimura Takaya Higaki Takenori Haruna Yohei Noda Kengo Kanai Shin Kariya Kazunori Nishizaki |
spellingShingle |
Seiichiro Makihara Mitsuhiro Okano Tazuko Fujiwara Masayo Kimura Takaya Higaki Takenori Haruna Yohei Noda Kengo Kanai Shin Kariya Kazunori Nishizaki Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial Allergology International early interventional treatment ECP intranasal corticosteroids Japanese cedar/cypress pollinosis total nasal symptom score |
author_facet |
Seiichiro Makihara Mitsuhiro Okano Tazuko Fujiwara Masayo Kimura Takaya Higaki Takenori Haruna Yohei Noda Kengo Kanai Shin Kariya Kazunori Nishizaki |
author_sort |
Seiichiro Makihara |
title |
Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial |
title_short |
Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial |
title_full |
Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial |
title_fullStr |
Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial |
title_full_unstemmed |
Early Interventional Treatment with Intranasal Mometasone Furoate in Japanese Cedar/Cypress Pollinosis: A Randomized Placebo-Controlled Trial |
title_sort |
early interventional treatment with intranasal mometasone furoate in japanese cedar/cypress pollinosis: a randomized placebo-controlled trial |
publisher |
Elsevier |
series |
Allergology International |
issn |
1323-8930 |
publishDate |
2012-01-01 |
description |
Background: Little is known about the safety and effectiveness of early interventional treatment (EIT) with intranasal corticosteroids for seasonal allergic rhinitis. We designed a double-blinded, randomized, placebo-controlled 12-week trial of EIT with mometasone furoate nasal spray (MFNS) for Japanese cedar/cypress pollinosis (JCCP).
Methods: A total of 50 JCCP patients received MFNS (200 ^g once daily: n = 25) or placebo (n = 25) starting on February 1, 2010. Treatments continued until the end of April. The primary endpoint was the comparison of the total nasal symptom score (TNSS) between the MFNS and placebo groups. The secondary endpoints included comparisons of QOL, daytime sleepiness, nasal ECP levels, and safety.
Results: Continuous dispersion of Japanese cedar pollen began on February 22. Although the placebo group showed a significant worsening of symptoms after the start of the continuous dispersion, no worsening occurred in the MFNS group. A significant difference in the TNSS between the two groups was seen starting at 4 weeks after the treatment. Similar results were seen for QOL and sleepiness. Nasal ECP levels in March were significantly lower in the MFNS group. A total of 56% of the MFNS group progressed to a persistent allergic rhinitis state in accordance with the ARIA classification, as opposed to 84% of the placebo group. MFNS was well tolerated, and the plasma cortisol concentrations were similar between the two groups.
Conclusions: EIT with MFNS for JCCP is both safe and effective. This treatment can potentially lessen symptoms and help pollinosis patients remain in the intermittent state. |
topic |
early interventional treatment ECP intranasal corticosteroids Japanese cedar/cypress pollinosis total nasal symptom score |
url |
http://www.sciencedirect.com/science/article/pii/S1323893015302239 |
work_keys_str_mv |
AT seiichiromakihara earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT mitsuhirookano earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT tazukofujiwara earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT masayokimura earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT takayahigaki earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT takenoriharuna earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT yoheinoda earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT kengokanai earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT shinkariya earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial AT kazunorinishizaki earlyinterventionaltreatmentwithintranasalmometasonefuroateinjapanesecedarcypresspollinosisarandomizedplacebocontrolledtrial |
_version_ |
1725760077889011712 |